OmniAb, Inc.

As of September 3, 2025, OmniAb, Inc. is in a bearish trend with weak strength, indicated by daily moving averages and monthly MACD signals, while underperforming the S&P 500 with a year-to-date return of -53.11%.

As of May 20, 2022, OmniAb, Inc. is rated as "risky" and overvalued, with key financial ratios indicating distress, a year-to-date return of -54.52%, and significantly lower valuation metrics compared to peers like BrightView Holdings and CRA International.

As of June 20, 2025, OmniAb, Inc. shows a bearish trend with moderate strength, indicated by mixed signals from MACD and Bollinger Bands, while KST and OBV confirm a bearish outlook.

OmniAb, Inc. is a micro-cap company in the miscellaneous industry, reporting net sales of $4 million and a net loss of $18 million as of March 2025, with a market cap of $207.97 million. Key metrics include a P/E ratio of NA, a dividend yield of 0.00%, and a return on equity of -22.66%.

As of Jun 18, OmniAb, Inc. has a market capitalization of 207.97 million, with net sales of 26.73 million and a net profit of -61.27 million over the latest four quarters. Shareholder's funds are 287.62 million, and total assets amount to 358.63 million as of Dec 24.